Every session I had, I felt peaceful, cared for, and confident with the treatment I was receiving
This genetic test identifies your response to GLP-1 pathways across 14 signaling cascades and 49 peptides, informing whether you're better suited for semaglutide, tirzepatide, or a dual-compound approachoptimizing both efficacy and cost-efficiency of your HSA dollars
Vitamin B12 is a requirement your body needs to function properly, as well as the development of the brain, nerves, blood cells and so much more
Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment
